The flavonoid fraction was obtained from Elsholtiza bodinieri Vaniot (EBV) by ethanol-reflux and liquid-liquid extraction. The total content of flavonoid was 179.55 mg/g, and the purity was 64.6%. Then cynaroside with the purity of 94% was isolated from the fraction by preparative HPLC and characterized by the combined usage of HPLC, ESI-MS, and NMR. The antioxidant activity of cynaroside was determined using 2 complementary methods, namely, 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging and reducing power assay. The anti-inflammatory effect of cynaroside was investigated based on in-vitro and invivo experiment. The results showed that cynaroside from EBV scavenged DPPH radical and reduced Fe 3+ to Fe 2+ effectively, inhibited NO and ROS production in LPS-stimulated RAW264.7 cells and attenuated the inflammation in the mouse model significantly (p < 0.01), which showed it to be a nutraceutical product in the food industry.
Cynaroside is an important flavonoid from EBV with a molecular formula of C 21 H 20 O 11 , and the chemical structural formula of cynaroside is shown in Figure 1 . However, it was usually extracted by multi-step liquid-liquid extraction with some challenges [12] . In the present study, we extracted the total flavonoids from EBV using an alcohol reflux method. Next, to avoid the disadvantages in traditional extraction (such as low separation efficiency, slow analysis, and low detection sensitivity), preparative HPLC was used for the first time to isolate cynaroside from the flavonoids of EBV. Finally, the antioxidant and anti-inflammatory activities of cynaroside were tested.
UV-Vis spectrophotometry was used to monitor the total flavonoids content. Rutin was selected as a calibrator to carry out content determination and there was a strong linear correlation between absorbance and rutin concentration (Y = 0.1024 + 15.7150X, r = 0.9999). Based on the standard curve, the total flavonoids content in the fraction of EBV was calculated to be 179.55 mg/g with the purity of 64.6%.
The total flavonoids extract was analyzed by HPLC. As shown in Figure 1A , the highest response peak was chosen as the target compound to proceed further with preparative HPLC. A compound with a purity of 94% calculated by area normalization ( Figure 1B ) was yielded and preliminarily considered as cynaroside by comparing the retention time of cynaroside standard ( Figure 1C ). To confirm the target compound, ESI-MS, 1 H-NMR and 13 C-NMR were applied to characterize the structural properties [13] . The DPPH radical scavenging capacity and ferric reducing antioxidant power (FRAP) assays are widely used to evaluate antioxidant activity. In the test of DPPH radical scavenging activity, on account of reaction kinetics, the equilibration time of the system was about 100 min. DPPH radical scavenging capacity of cynaroside at different concentration was shown in Figure 2A .
There was a good linear relation at a concentration range of 1.125-9 μg/mL so that a fitted equation y = 6.4155 + 11.9095x (R = 09978) could be obtained by regressive analysis. Using this equation, the IC 50 of cynaroside on DPPH radical scavenging was 5.14 μg/mL, which was slightly higher than the IC 50 of ascorbic acid (3.32 µg/mL). However, in units of µM, the IC 50 of DPPH radical scavenging of cynaroside (11.46 µM) was clearly lower than that of ascorbic acid (18.84 µM). IC 50 of DPPH radical scavenging of cynaroside from EBV exhibited stronger antioxidant activity, compared with glucoluteolin extracted from Rhopalocnemis phalloides (47.1 µM and 52.3 µM, respectively; 17.6 µM of ascorbic acid as a positive control) [14] . In FRAP assay, the ability of cynaroside to reduce Fe 3+ to Fe 2+ was determined and presented in Figure 2B . A strong correlation (R = 0.9946) between the ferric reducing antioxidant power and cynaroside concentration was displayed, which did exhibit definite reducing power activity. Based on the above tests, cynaroside from EBV exhibited a wide range of antioxidant activities and had the potential to reduce the risk of oxidation-related diseases, such as inflammation.
The anti-inflammatory effect of cynaroside was observed based on in-vitro cell experiment and in-vivo animal experiment. In vitro test, compared with untreated RAW264.7 cells, NO production in LPSstimulated cells increased significantly ( Figure 3A) . However, the addition of cynaroside resulted in a significant reduction of NO production in LPS-treated cells (p < 0.01). And the effect of cynaroside on NO production in LPS-stimulated RAW264.7 cells was dose-dependent manner. These results indicated that cynaroside could inhibit NO production effectively. Another study on the effect of cynaroside on ROS generation in LPS-stimulated RAW264.7 cells came to a similar conclusion ( Figure 3B ). NO is a proinflammatory mediator that can cause a systemic inflammatory response [15] . ROS are known to play an important role in the activation of several pro-inflammatory genes [16] . Cynaroside exhibited anti-inflammation activity through suppressing LPSinduced NO and ROS production in this study.
In-vivo test revealed that the inhibition of xylene-induced edema and the decreased level of PGE 2 in the serum of mice represented a useful way to assess potential anti-inflammatory effect [17, 18] . In Figure 4 , xylene increased the degree of ear edema. However, the ear swelling degree significantly decreased in the presence of cynaroside. Indeed, the edema volumes were reduced by 62.9-81.4% in the treated groups compared to the control group, as shown in Table 1 . Furthermore, the high dose (80 mg/kg, equal to 0.178 mmol/kg) significantly inhibited ear edema in comparison to that of the control group (p < 0.01). A few other flavonoid compounds, including kaempferol 3-O-rutinoside and kaempferol 3-O-glucoside, attained an equivalent anti-inflammatory effect until the administration dose reached more than 800 mg/kg (1.34 mmol/kg). For context, kaempferol showed significant antiinflammatory activity, but it was still slightly lower than cynaroside [19, 20] . Prostaglandin PGE 2 , generated by specific COX-2, is an antiinflammatory biomarker [18] . It can trigger inflammation when local tissues are inflamed and the permeability of capillaries increase [21] . Thus, PGE 2 is an important indicator of the degree of inflammation. In xylene-induced models of inflammation, the antiinflammatory effects of cynaroside were closely attributed to the decreased levels of PGE 2 . As shown in Table 3 , the content of PGE 2 in the low-and medium-dose groups showed a similar result to that of the model group. However, the content of PGE 2 in the high-dose 
group was significantly reduced compared with that of the control group. Moreover, the high-dose group has ~40% of the PGE 2 as the control group contained, so the anti-inflammatory effect of cynaroside depended on the dose, and high dose cynaroside had clear anti-inflammatory actions. These findings yielded a rational reason for the use of cynaroside from EBV as an anti-inflammatory agent. Table 1 : Effects of cynaroside on xylene-induced ear edema and PGE 2 concentrations in the serum of mice. Compared with the control group, *P < 0.05, **P < 0.01. Data are presented as means ± standard deviation (n = 5).
Experimental
Plant material: EBV was collected in Wenshan of Yunnan province, China and identified by Prof. Liu Wei from Chengdu University of Traditional Chinese Medicine. EBV was washed thoroughly, and then dried using a hot-air oven at 40 °C, and finally powdered and maintained in the dark.
Extraction and determination of total flavonoids: EBV powder was refluxed twice with 60% aqueous ethanol solution for 1 h. After filtration, the solution was evaporated to dryness and then dissolved in distilled water. The total flavonoids were then obtained via liquid-liquid extraction with isometric saturated n-butyl alcohol.
Measurements of the total flavonoids content from EBV were conducted by NaNO 2 -Al(NO) 3 -NaOH spectrophotometry [22] . Briefly, a series of standard solutions ranging from 1.0 to 0.2 mg/mL were prepared to determine the linearity. Rutin was used as a standard, and 0.1 mL samples were placed in a 25-mL volumetric flask. Then, the samples were mixed with 1 mL NaNO 2 (5%) for 6 min, and 1 mL AlCl 3 (10%) for 15 min. The reaction was stopped with 10 mL NaOH (4%), and a total volume of 25 mL was obtained by adding distilled water. The solution was mixed well, and the absorbance of the mixture was measured at 510 nm after incubation for 15 min. Subsequently, a standard curve with absorbance (A) and concentration (C) was drawn. Each test was conducted in triplicate.
Isolation and characterization of cynaroside:
Cynaroside was separated from the total flavonoids of EBV using preparative HPLC. A Zorbax SB-C18 column (150  21.2 mm, 5 µm) was selected as a chromatographic column. Gradient elution was performed using H 2 O (A) and acetonitrile (B) with the following linear gradient combinations: 15% B-20% B (0-20 min), 100% B (20.01-21 min). The column temperature was 25 °C. The flow rate was 21 mL/min, and 100 µL samples were injected. The detection wavelength was 254 nm. Purity was analyzed using HPLC with a Kromasil C-18 Column (250 4.6 mm, 5 µm, Switzerland).
The chemical structure of cynaroside was elucidated by UPLC-TOF-MS. The flow rate was 0.3 mL/min, and the injection volume was 20 µL. Deionized water and acetonitrile (5%) were used as mobile phase A and B, respectively. The mobile phase of the gradient procedure was 5-10% B for 0-12 min, 10-25% B for 12-25 min, 25-80% B for 25-32.5 min, and 80-5% B for 32.5-35 min. The column temperature was maintained at 25 °C. Detection was performed at 254 nm. The mass spectrometer used was a time of flight mass spectrometer equipped with an ESI source. The mass parameters were as followed: capillary voltage, 84.9 V; fragmentation voltage, 17.4 V; drying gas temperature, 365°C; and gas flow (N 2 ), 9 L/min. The ESI mass spectra were scanned from m/z 80 to 1000 at a scan rate of 1.5 sec/cycle. In addition, 1 H and 13 C NMR were used to confirm the chemical structure of this compound.
Antioxidant activity assay:
The antioxidant activity of cynaroside was expressed based on the scavenging activity of DPPH radicals [23] and ferric reducing antioxidant power (FRAP) [24] . Cynaroside was dissolved in ethanol and diluted to 0.1125 mg/mL. Gradient volumes (0.02, 0.05, 0.1, 0.15, and 0.2 mL) of the solution were mixed with 2 mL of a 0.2 mmol/L ethanol solution of DPPH and diluted to 5 mL with ethanol. Finally, the absorbance of the mixture was measured at 517 nm after incubation in the dark until the system was stable. The absorbance of the positive reference (ascorbic acid) and control (DPPH radical without antioxidant) was also measured. The reaction dynamics were studied, and the percentage of DPPH free-radical scavenging activity was calculated using the following equation:
Scavenging activity (%) = (1-Ab 1 /Ab 0 )  100. Ab 1 and Ab 0 were the absorbances of sample and control respectively.
Antioxidant activity was expressed as IC 50 values. Here, IC 50 values were referred to as a concentration of a sample with a 50% DPPH radical scavenging rate. IC 50 was calculated by the linear equation obtained based on the concentration and inhibition percentage. All samples were analyzed in triplicate.
After the cynaroside solution was diluted to 0.225 mg/mL, different volumes of the solution were mixed with 2.5 mL of 0.2 mol/L phosphate buffer (PBS, pH = 6.6) and 2.5 mL of 1% potassium ferricyanide (K 3 Fe(CN) 6 ); next, the mixture was diluted to 6 mL with distilled water and incubated for 20 min at 50 °C and then 2.5 mL 10% trichloroacetic acid (TCA) was added. Subsequently, the mixtures were centrifuged, and the supernatant (5 mL) was mixed with 5 mL distilled water and 1 mL 0.1% ferric chloride (FeCl 3 ). Absorbance was measured at 700 nm after the mixtures were incubated at room temperature for 10 min. An increase of absorbance indicated the reducing power of samples. All samples were tested in triplicate.
Anti-inflammatory activity assay:
In-vitro anti-inflammatory activity was evaluated according to the effect of cynaroside on NO and ROS production in LPS-stimulated RAW264.7 cells. RAW264.7 cells were obtained from the cell bank of the Chinese Academy of Science (Shanghai, China). The cells were cultured in RPMI-1640 medium containing 10% heat-inactivated fetal bovine serum (FBS) and incubated at 37 o C and 5% CO 2 . NO production was measured using the Griess method. The cells were pretreated with cynaroside (0, 5, 25, 125, 250, 500 and 300 μg/mL) for 1 h prior to stimulation with or without LPS (1 μg/mL) for 24 h. The cells were collected, lysed and centrifuged. And the supernatant was retained. In 96-well plates, the sample supernatant (50 μL) was mixed with Griess reagent (100 μL) for 5 min. And the absorbance at 540 nm was determined using a microplate reader [25] . ROS production was measured using flow cytometry. RAW264.7 cells were pretreated with cynaroside (0, 5, 25, 125 and 250 μg/mL) for 1 h prior to stimulation with or without LPS (1 μg/mL) for 24 h. The cells were washed, and the supernatant was retained. Subsequently, cells were treated with 10 µM of DCFH-DA and then incubated in the dark for 30 min with 5% CO 2 at 37 o C. At last, cells were washed twice and placed on ice to be tested by flow cytometry [26] .
In-vivo anti-inflammatory activity was evaluated in a xyleneinduced auricular swelling mice model. ICR mice (specific pathogen-free) were purchased from SLRC laboratory animals (Shanghai, China). Mice were housed with a 12-h light-dark cycle under constant temperature (26 °C ± 2 °C) and humidity (60 ± 10%), provided with free access to tap water and food. Cynaroside was dissolved in distilled water. After a two-week adaptation period, 30 mice (34-40 g) were randomly divided into 5 groups (n = 6, either sex): (1) blank group, saline (0.2 mL/10 g); (2) control group, saline (0.2 mL/10 g); (3-5) treatment groups, low-dose, medium-dose, and high-dose (40, 60, 80 mg/kg). The administration was performed intra-gastrically once daily for a period of 7 days prior to the inflammation-inducer challenge. Next, 30 min after the last oral administration, all groups except for the blank group received 0.05 mL xylene in the right ear; the left ear served as a control. At 30 min after treatment with inflammation inducers, blood was collected from the orbital socket, and the levels of PGE 2 were measured using a kit. Mice were killed by cervical dislocation after another 1 h of xylene treatment, and 3 ear biopsies of 8.0 mm in diameter were punched in each ear. The degree of swelling was calculated based on differences in values between the weight of the left and right ear biopsies of different groups. All animal procedures were approved by the Committee for Animal Research of Shanghai Ocean University, China, and were also carried out according to the Guide for the Care and Use of Laboratory Animals.
